| Literature DB >> 33921633 |
Tania Martín-Pérez1, Irene Heredero-Bermejo1, Cristina Verdú-Expósito1, Jorge Pérez-Serrano1.
Abstract
Ameobae belonging to the genus Acanthamoeba are responsible for the human diseases Acanthamoeba keratitis (AK) and granulomatous amoebic encephalitis (GAE). The treatment of these illnesses is hampered by the existence of a resistance stage (cysts). In an attempt to add new agents that are effective against trophozoites and cysts, tea tree oil (TTO) and dimethyl sulfoxide (DMSO), separately and in combination, were tested In Vitro against two Acanthamoeba isolates, T3 and T4 genotypes. The oxygen consumption rate (OCR) assay was used as a drug screening method, which is to some extent useful in amoebicide drug screening; however, evaluation of lethal effects may be misleading when testing products that promote encystment. Trophozoite viability analysis showed that the effectiveness of the combination of both compounds is higher than when either compound is used alone. Therefore, the TTO alone or TTO + DMSO in combination were an amoebicide, but most of the amoebicidal activity in the combination's treatments seemed to be caused mainly by the TTO effect. In fact, DMSO alone seems to be a non-amoebicide, triggering encystment. Regarding cytotoxicity, these compounds showed toxicity in human corneal epithelial cells (HCEpiC), even at low concentrations when tested in combination. In conclusion, the use of TTO and DMSO, in combination or alone, cannot be recommended as an alternative for AK treatment until more cytotoxicity and cyst adhesion tests are performed.Entities:
Keywords: Acanthamoeba spp.; cysts; cytotoxicity; dimethyl sulfoxide; drug screening; genotype T3; genotype T4; tea tree oil
Year: 2021 PMID: 33921633 PMCID: PMC8073477 DOI: 10.3390/pathogens10040491
Source DB: PubMed Journal: Pathogens ISSN: 2076-0817
Figure 1Respiration plot of A. griffini MYP2004 treated with tea tree oil (TTO) and dimethyl sulfoxide (DMSO).
Figure 2DMSO treatment in trophozoites of A. griffini MYP2004. Photographs obtained under the light microscope. (a) Trophozoites observed in the control. (b) Trophozoites treated with 0.625% DMSO. (c) Cysts observed at a concentration of 1.25% DMSO. (d) Cysts observed at a concentration of 2.5% DMSO.
Figure 3DMSO treatment in trophozoites of A. polyphaga 2961. Photographs obtained under the light microscope. (a) Trophozoites observed in the control. (b) Trophozoites treated with 0.625% DMSO. (c) Cysts observed at a concentration of 1.25% DMSO. (d) Cysts observed at a concentration of 2.5% DMSO
Figure 4Viability percentages of A. griffini MYP2004 and A. polyphaga 2961 after 4-h and 24-h treatment. (a) Treated with TTO. (b) Treated with DMSO. (c) Treated with TTO + DMSO.
The minimum trophozoite amoebicidal concentration (MTAC) of TTO, DMSO and TTO + DMSO in trophozoites of A. griffini MYP2004 and A. polyphaga 2961 after 24 h of treatment. The minimum cystidal concentration (MCC) of TTO, DMSO and TTO + DMSO after 24 h of treatment. Data shown % v/v.
| MTAC | MCC | MTAC | MCC | |
|---|---|---|---|---|
| TTO | 0.5 | >1 | 0.5 | >1 |
| DMSO | >1.25 | >1.25 | >1.25 | >1.25 |
| TTO+DMSO | 0.25 + 1.25 | >0.5 + 2.5 | 0.12 + 0.625 | >0.5 + 2.5 |
Fractional inhibitory concentration index (FICI) of the combination therapy of TTO and DMSO against A. griffini MYP2004 and A. polyphaga 2961.
|
|
|
| |||
|
|
|
|
| ||
| 0.5 | 1.25 | 0.25 | 1.25 | 1.5 | Indifference |
|
|
|
| |||
|
|
|
|
| ||
| 0.5 | 1.25 | 0.12 | 0.625 | 0.74 | Indifference |
Figure 5Cytotoxic test in human corneal epithelial cell (HCEpiC) line. (a) Treated with TTO. (b) Treated with DMSO. (c) Treated with TTO + DMSO.